The Third Annual Cardiovascular Disease in African-Americans Conference

Transcription

1 Sponsored by: The Ohio State University Medical Center in Cooperation with Ohio State s Heart and Vascular Center and Division of Cardiovascular Medicine The Third Annual Cardiovascular Disease in African-Americans Conference April :30 p.m. The Ohio State University s Biomedical Research Tower Auditorium 460 W. 12th Ave. Columbus Featuring Clyde Yancy, MD, MSc Northwestern Memorial Hospital Northwestern Feinberg School of Medicine Herman Taylor, MD, MPH University of Mississippi Medical Center Jackson State University

2 Sponsored by: The Ohio State University Medical Center in Cooperation with Oh The Third Annual Cardiovascular Disease in African-Americans Conference April :30 p.m. The Ohio State University s Biomedical Research Tower Auditorium 460 W. 12th Ave. Columbus Like all Americans, the leading cause of death in African- Americans is cardiovascular disease. Although there have been improvements in the treatment of heart disease and stroke that, combined with preventive measures, have reduced cardiovascular morbidity and mortality in this country, the improvements in cardiovascular outcomes in African- Americans has lagged behind those of White Americans. This conference focuses on evidence-based treatments that prevent and retard the progression of cardiovascular disease in African-Americans. Participants will also review certain aspects of racial disparities in cardiovascular care while also discussing possible solutions.

3 io State s Heart and Vascular Center and Division of Cardiovascular Medicine Target audience: Cardiologists Internal Medicine Physicians Family Practice Physicians Fellows in Training Nurses Allied Health Professionals At the conclusion of this activity, participants should be able to: Describe the current epidemiology of cardiovascular disease in African- Americans in the USA and the role of risk factors in African Americans Recognize the role of hospitals in racial disparities in cardiovascular care List three strategies to reduce racial disparities in cardiovascular care Describe the current approach to and management of acute ST segment elevation acute myocardial infarction Describe the concept of pharmacogenetics as it applies to hypertension in African-Americans Identify the epidemiology, medical management and surgical management of congestive heart failure in African-Americans

4 The Third Annual Cardiovascular Disease in African-Americans Conference Featuring Clyde Yancy, MD, MSc Magerstadt Professor Chief, Division of Cardiology Northwestern Memorial Hospital Northwestern Feinberg School of Medicine Clyde Yancy, MD, MSc, is the Magerstadt Professor and chief of the Division of Cardiology at Northwestern University Feinberg School of Medicine and associate director of The Bluhm Cardiovascular Institute at Northwestern Memorial Hospital. Until recently Dr. Yancy was the medical director at Baylor Heart and Vascular Institute and chief of Cardiothoracic Transplantation at Baylor University Medical Center. He co-chairs the Coalition to Reduce Racial and Ethnic Disparities in Cardiovascular Outcomes sponsored by the American College of Cardiology (ACC). He has served as president of the American Heart Association (AHA) and on the Executive Council of the Heart Failure Society of America. He is a member of the ACC Guideline Taskforce that oversees all ACC/AHA guidelines. His research interests include the emerging role of registries in cardiovascular diseases, management of advanced heart failure with new drugs and devices and heart failure in special populations. And Herman Taylor, MD, MPH Professor of Medicine University of Mississippi Medical Center Clinical Professor of Epidemiology and Preventive Medicine Jackson State University Director/Principal Investigator of the Jackson Heart Study Jackson, Mississippi Herman A. Taylor, MD, MPH, is Professor of Medicine at University of Mississippi Medical Center, Clinical Professor of Epidemiology and Preventive Medicine at Jackson State University, and Director/Principal Investigator of the Jackson Heart Study (JHS) in Jackson, Mississippi. The landmark JHS is the largest populationbased study of heart and related diseases ever undertaken in African Americans. While the study seeks to answer questions about cardiovascular disease risk in the African-American population, it also provides historically black colleges and universities experience in large-scale epidemiological research. In addition, a new generation of African-American students is able to prepare for leadership roles in science and medicine. The JHS is funded by the National Heart, Lung and Blood Institute and the National Center on Minority Health and Health Disparities of the National Institutes of Health.

5 April 21, 2011 Agenda 11:30 a.m. Lunch and Registration 1 p.m. Welcome William Abraham, MD Quinn Capers IV, MD, Course Director Cardiomyopathy and Heart Failure 1:15 p.m. Evidence-Based Management of Diastolic Congestive Heart Failure and the Promise of Implanted Hemodynamic Monitoring Devices William Abraham, MD 1:35 p.m. Evidence-Based Management of Systolic Congestive Heart Failure Clyde Yancy, MD,MSc 1:55 p.m. Evidence-Based Approach to the Prevention and Management of Cardiac Arrest David Hart, MBBS 2:15 p.m. Cardiac Transplantation in African-Americans Robert Higgins, MD, MSHA 2:35 p.m. Break/Refreshments Special Considerations in Epidemiology 2:50 p.m. Update on the Jackson Heart Study: The Black Framingham Herman Taylor, MD, MPH 3:10 p.m. Focus on African-American Women: Epidemiology and Approach to Prevention and Management of Cardiovascular Disease Martha Gulati, MD 3:30 p.m. Air Pollution as a Risk Factor for Cardiac Disease: What is the Evidence? Sanjay Rajagopalan, MBBS

6 The Third Annual Cardiovascular Disease in African-Americans Conference Agenda cont. 3:50 p.m. Evidence-Based Management of Acute ST elevation MI in African-Americans Quinn Capers IV, MD 4:10 p.m. Evidence-Based Management of HTN in African-Americans: Impact of Genetics on Pharmacotherapy Gbemiga Sofowora, MB/ChB 4:30 p.m. Break/Refreshments Update on Racial Disparities in Cardiovascular Care 4:45 p.m. Update on Racial Disparities in Cardiovascular Care: Focus on Hospital Quality Quinn Capers IV, MD 5:05 p.m. A Prescription to Eliminate or Reduce Racial Disparities in Cardiovascular Care Clyde Yancy, MD, MSc 5:25 p.m. Closing Comments Thomas Ryan, MD 5:30 p.m. Course Adjourns The Ohio State University Medical Center Faculty William Abraham, MD Professor of Internal Medicine and of Physiology and Cell Biology Chair of Excellence in Cardiovascular Medicine Director, Division of Cardiovascular Medicine Quinn Capers IV, MD Course Director Assistant Professor of Clinical Internal Medicine Associate Dean for Admissions at Ohio State s College of Medicine Director of Peripheral Vascular Interventions Martha Gulati, MD Sarah Ross Soter Chair in Women s Cardiovascular Health at The Ohio State University Section Director for Preventive Cardiology and Women s Cardiovascular Health Associate Professor of Clinical in the Department of Internal Medicine David Hart, MBBS Assistant Professor of Clinical Internal Medicine Division of Cardiovascular Medicine

7 April 21, 2011 Robert Higgins, MD, MSHA John H. and Mildred C. Lumley Chair in Medicine Director of Ohio State s Comprehensive Transplant Center Professor and Director of the Division of Cardiac Surgery Sanjay Rajagopalan, MBBS John W. Wolfe Professor in Cardiovascular Research Section Director of Vascular Medicine Co-Director Ohio State s Cardiovascular MR/CT Program Thomas Ryan, MD Director of Ohio State s Heart and Vascular Center John G. & Jeanne Bonnet McCoy Chair in Cardiovascular Medicine Professor in the Department of Internal Medicine Guest Faculty Herman Taylor, MD, MPH Professor of Medicine University of Mississippi Medical Center Clinical Professor of Epidemiology and Preventive Medicine Jackson State University Director/Principal Investigator of the Jackson Heart Study Jackson, Mississippi Clyde Yancy, MD, MSc Magerstadt Professor Chief of the Division of Cardiology Northwestern Memorial Hospital Northwestern Feinberg School of Medicine Chicago, Illinois Gbemiga Sofowora, MB/ChB Assistant Professor of Clinical Internal Medicine Ohio State s Division of Cardiovascular Medicine Accreditation: The Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. The Ohio State University Medical Center designates this educational activity for a maximum of 4 AMA PRA Category 1 Credits. Physicians should claim credit commensurate with the extent of their participation in the activity. This course is free, but seating is limited and registration required. To register, visit ccme.osu.edu and click Show all Conferences. Fax registration form to or mail your completed registration form to: The Ohio State University Medical Center Division of Cardiovascular Medicine Davis Heart & Lung Research Institute Ste 226, Attn: Ellen Yokoyama 473 W. 12th Ave Columbus, OH If you have any questions, please call Ellen Yokoyama at Name Degree Specialty Address City State ZIP Phone Fax

8 The Third Annual Cardiovascular Disease in African-Americans Conference The Ohio State University Heart and Vascular Center PO Box Columbus, OH April 21 Featuring Clyde Yancy, MD, MSc Magerstadt Professor Chief, Division of Cardiology Northwestern Memorial Hospital Northwestern Feinberg School of Medicine Presort First Class U.S. Postage PAID Columbus, OH Permit No. 711